Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 22, 2021

SELL
$9.73 - $13.38 $2.16 Million - $2.97 Million
-222,059 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$9.53 - $15.42 $17,154 - $27,756
1,800 Added 0.82%
222,059 $2.59 Million
Q4 2020

Jan 22, 2021

SELL
$10.35 - $15.94 $3,674 - $5,658
-355 Reduced 0.16%
220,259 $2.33 Million
Q3 2020

Oct 14, 2020

SELL
$10.24 - $19.58 $1,638 - $3,132
-160 Reduced 0.07%
220,614 $2.69 Million
Q2 2020

Jul 30, 2020

SELL
$9.71 - $17.87 $2.02 Million - $3.73 Million
-208,500 Reduced 48.57%
220,774 $2.57 Million
Q1 2020

Apr 22, 2020

SELL
$5.57 - $10.76 $83,550 - $161,400
-15,000 Reduced 3.38%
429,274 $4.62 Million
Q4 2019

Jan 30, 2020

SELL
$7.21 - $8.89 $57,319 - $70,675
-7,950 Reduced 1.76%
444,274 $3.57 Million
Q3 2019

Oct 21, 2019

BUY
$6.57 - $9.46 $279,882 - $402,996
42,600 Added 10.4%
452,224 $3.38 Million
Q2 2019

Jul 23, 2019

SELL
$8.17 - $11.07 $349,063 - $472,965
-42,725 Reduced 9.45%
409,624 $3.8 Million
Q1 2019

May 01, 2019

BUY
$9.63 - $13.09 $258,084 - $350,812
26,800 Added 6.3%
452,349 $5.04 Million
Q4 2018

Jan 22, 2019

SELL
$10.53 - $15.54 $51,597 - $76,146
-4,900 Reduced 1.14%
425,549 $4.97 Million
Q3 2018

Oct 19, 2018

BUY
$15.25 - $17.72 $2.93 Million - $3.4 Million
191,925 Added 80.46%
430,449 $6.65 Million
Q2 2018

Jul 19, 2018

SELL
$14.46 - $18.08 $49,525 - $61,923
-3,425 Reduced 1.42%
238,524 $3.93 Million
Q1 2018

Apr 12, 2018

SELL
$16.77 - $22.04 $79,657 - $104,690
-4,750 Reduced 1.93%
241,949 $4.09 Million
Q4 2017

Jan 17, 2018

SELL
$13.44 - $22.81 $3.34 Million - $5.66 Million
-248,199 Closed
0 $0
Q3 2017

Nov 06, 2017

BUY
$19.97 - $22.74 $4.96 Million - $5.64 Million
248,199
248,199 $5.58 Million

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $273M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Sicart Associates LLC Portfolio

Follow Sicart Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sicart Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sicart Associates LLC with notifications on news.